Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 82 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8361459

    Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  2. US 8357718

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  3. US 8354419

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  4. US 8354436

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  5. US 8349888

    Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  6. US 8349353

    Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  7. US 8350042

    Antiviral compounds for the treatment of HCV infection

    The Regents of the University of California · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  8. US 8337866

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    The Regents of the University of California · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  9. US 8338397

    Composition and method of treating side effects from antibiotic treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  10. US 8334313

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  11. US 8334297

    2,4-pyrimidinediamine compounds for treatment of inflammatory disorders

    Rigel Pharmaceuticals, Inc. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  12. US 8329719

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  13. US 8329636

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  14. US 8328785

    Use of nanoparticles in the photodynamic treatment of tumors

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  15. US 8329924

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  16. US 8324192

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  17. US 8322588

    Structure containing wound treatment material

    Covidien LP · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  18. US 8324178

    Method of treatment using alpha-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  19. US 8324275

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  20. US 8323617

    Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

    ANIKA THERAPEUTICS, INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  21. US 8318156

    Anti-cocaine compositions and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  22. US 8318817

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  23. US 8309525

    Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted

  24. US 8303985

    Skin treatment compositions containing copper-pigment complexes

    Discovery Limited · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.